BioSpace News Archive

BioMidwest

Real-world Study of SPRINT 60-day Peripheral Nerve Stimulation (PNS) Corroborates Published Clinical Study Results

SPR Therapeutics announced the publication of a study that evaluated the real-world impact of 60-day peripheral nerve stimulation in the management of chronic pain.

May 6, 2022
·
3 min read
BioMidwest

Akadeum Life Sciences Unveils Cell Separation Product Expansion at American Association of Immunologist Annual Meeting

Akadeum Life Sciences, Inc. announced the expansion of its cell separation product portfolio with a new human B cell isolation product and updated protocol for its existing human isolation kits.

May 6, 2022
·
4 min read
Compound Management Market Growth – at a CAGR of 17.0% | Emergen Research

Increasing sample collection and transportation & storage activities and rising demand for compound management outsourcing services are some key factors supporting the global Compound Management market revenue growth.

May 6, 2022
·
7 min read
Near Infrared Spectroscopy Market Trends – Increasing Need for Medical Treatment Due to Rise in Prevalence of Various Chronic Diseases

Rising prevalence of chronic and acute diseases and increasing medical applications of near-infrared spectroscopy are some key factors contributing to the global near infrared spectroscopy market revenue growth.

May 6, 2022
·
7 min read
Cinitapride Market Analysis, Industry Size, Share Leaders, Current Status by Major Key vendors and Trends by Forecast to 2028

The data has been collected through extensive primary and secondary research and is validated by experts in the industry.

May 6, 2022
·
6 min read
Bio NC

BioCryst to Present at Upcoming Investor Conferences - May 06, 2022

BioCryst Pharmaceuticals, Inc. announced that the company will present at the following conferences:.

May 6, 2022
·
1 min read
Pharm Country

VYNE Therapeutics to Present at LifeSci Partners’ Immunology & Inflammation Symposium on May 10th

VYNE Therapeutics Inc. announced that David Domzalski, Chief Executive Officer, and Dr. Iain Stuart, Chief Scientific Officer, will present at LifeSci Partners’ virtual Immunology and Inflammation Symposium, taking place May 10th-11th, 2022.

May 6, 2022
·
1 min read
Business

Humacyte to Present First Quarter 2022 Financial Results and Provide Recent Corporate Update on May 13, 2022

Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissue at commercial scale, will release its financial results for the first quarter ended March 31, 2022, on Friday, May 13, 2022.

May 6, 2022
·
2 min read
Business

VolitionRx Limited Schedules First Quarter 2022 Earnings Conference Call and Business Update

VolitionRx Limited (NYSE AMERICAN: VNRX) (“Volition”) today announced it will host a conference call on Thursday May 12, at 08.30 a.m. Eastern Time to discuss its financial and operating results for the first quarter 2022, in addition to providing a business update.

May 6, 2022
·
3 min read
Business

Athersys Reports First Quarter 2022 Results

Athersys, Inc. (NASDAQ: ATHX) announced today its financial results for the three months ended March 31, 2022.

May 6, 2022
·
13 min read